A detailed history of Invesco Ltd. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Invesco Ltd. holds 119,698 shares of ORGO stock, worth $462,034. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119,698
Previous 267,147 55.19%
Holding current value
$462,034
Previous $748,000 54.28%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.42 - $3.24 $356,826 - $477,734
-147,449 Reduced 55.19%
119,698 $342,000
Q2 2024

Aug 13, 2024

BUY
$2.28 - $3.03 $99,863 - $132,714
43,800 Added 19.61%
267,147 $748,000
Q1 2024

May 14, 2024

BUY
$2.61 - $4.49 $518,043 - $891,193
198,484 Added 798.31%
223,347 $634,000
Q4 2023

Feb 12, 2024

BUY
$1.97 - $4.21 $5,498 - $11,750
2,791 Added 12.64%
24,863 $101,000
Q3 2023

Nov 13, 2023

BUY
$2.34 - $4.43 $5,349 - $10,126
2,286 Added 11.55%
22,072 $70,000
Q2 2023

Aug 11, 2023

SELL
$1.9 - $4.3 $16,174 - $36,605
-8,513 Reduced 30.08%
19,786 $65,000
Q1 2023

May 12, 2023

SELL
$1.89 - $2.93 $1.63 Million - $2.52 Million
-861,453 Reduced 96.82%
28,299 $60,000
Q4 2022

Feb 13, 2023

BUY
$2.48 - $3.43 $731,798 - $1.01 Million
295,080 Added 49.62%
889,752 $2.39 Million
Q3 2022

Nov 14, 2022

BUY
$3.14 - $6.43 $212,951 - $436,076
67,819 Added 12.87%
594,672 $1.93 Million
Q2 2022

Aug 15, 2022

BUY
$4.74 - $8.15 $71,493 - $122,926
15,083 Added 2.95%
526,853 $2.57 Million
Q1 2022

May 16, 2022

SELL
$6.47 - $9.57 $357,558 - $528,876
-55,264 Reduced 9.75%
511,770 $3.9 Million
Q4 2021

Feb 14, 2022

BUY
$9.02 - $13.5 $1.81 Million - $2.7 Million
200,293 Added 54.61%
567,034 $5.24 Million
Q3 2021

Nov 15, 2021

BUY
$13.71 - $17.18 $1.26 Million - $1.58 Million
91,711 Added 33.35%
366,741 $5.22 Million
Q2 2021

Aug 17, 2021

SELL
$14.92 - $23.23 $2.44 Million - $3.8 Million
-163,382 Reduced 37.27%
275,030 $4.57 Million
Q1 2021

May 17, 2021

BUY
$7.33 - $21.06 $3.13 Million - $8.99 Million
427,096 Added 3774.27%
438,412 $7.99 Million
Q4 2020

Feb 16, 2021

BUY
$3.63 - $7.53 $41,077 - $85,209
11,316 New
11,316 $85,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $505M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.